Notably, there are studies suggesting a higher cancer incidence in approximately 5 to 10% of Neurofibromatosis type 1 patients who have a micro-deletion that includes NF1, ATAD5, and several other genes [41], [42]. This evidence concerns the gene NF1 and neurofibromatosis type 1.